Last reviewed · How we verify
NCT06950723
Chest Physical Therapy on Arterial Blood Gases for Neonates Post Hypoxic Ischemic Encephalopathy
NA trial testing Chest Physical Therapy (CPT) modalities , Medical Treatment in Hypoxic Ischemic Encephalopathy of Newborn in 50 participants. Not yet recruiting.
10 June 2025
Quick facts
| Lead sponsor | Cairo University |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 50 |
| Start date | 10 May 2025 |
| Primary completion | 10 June 2025 |
| Estimated completion | 15 July 2025 |
Drugs / interventions tested
- Chest Physical Therapy (CPT) modalities , Medical Treatment
Conditions studied
- Hypoxic Ischemic Encephalopathy of Newborn — all drugs for Hypoxic Ischemic Encephalopathy of Newborn →
Sponsor
Cairo University
Who can join
Adults 1 Day to 10 Days, any sex, with Hypoxic Ischemic Encephalopathy of Newborn. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Hypoxic-ischemic encephalopathy (HIE) is a dangerous illness that happens when a newborn's brain does not receive adequate oxygen and blood flow, which can result in serious effects such as cerebral palsy and epilepsy. Infant diagnosed with HIE required ventilator support and subsequently developed pneumonia. They experienced respiratory problems and feeding challenges. Chest Physical Therapy is the best modalities to clear chest and improve ventilation.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06950723
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hypoxic Ischemic Encephalopathy of Newborn
Currently open trials in the same condition.
- NCT06762795 — The HIEnome Study: Genome Sequencing for Perinatal HIE · NA · recruiting
- NCT06747260 — Feasibility and Safety of Intranasally Administered Breast Milk in HIE · EARLY_PHASE1 · recruiting
- NCT06563687 — Continuous Glucose Monitoring in HIE · NA · recruiting
- NCT06522581 — Role of Citicoline in Treatment of Neonates With Hypoxic Ischemic Encephalopathy · Phase 1 · recruiting
Other Cairo University trials
Trials by the same sponsor.
- NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
- NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
- NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
- NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
- NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06950723 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Cairo University
- Last refreshed: 30 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06950723.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing